Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 6.77
Key Takeaways
Risk factor
Fair trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Slightly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Jinhe Biotechnology CO., LTD. produces and sells veterinary medicines in China. The company offers chlortetracycline feed grade, an antimicrobial drug for the inhibition and treatment of white dysentery, enteritis, pneumonia, typhoid, paratyphoid, cholera, etc. in poultry and livestock; and chlortetracycline hydrochloride for the inhibition and treatment of pullorum disease, typhoid, and swine enteritis, as well...
Company Valuation
From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks. In particular, the stock is reasonably priced on P/E, of fair
Data is available to registered users only
Buy
Sell